Investigating mitochondrial bioenergetics and cellular repair mechanisms requires selecting peptides with distinct molecular targets and pharmacological profiles. This comparative guide analyzes the structural, mechanistic, and operational differences between SS-31 (Elamipretide) and Cell Factor in preclinical research models.
Investigating mitochondrial bioenergetics and cellular repair mechanisms requires selecting peptides with distinct molecular targets and pharmacological profiles. This comparative guide analyzes the structural, mechanistic, and operational differences between SS-31 (Elamipretide) and Cell Factor in preclinical research models.
SS-31 directly targets cardiolipin on the inner mitochondrial membrane to optimize electron transport chain efficiency and reduce reactive oxygen species (ROS) in damaged organelles. In contrast, Cell Factor acts primarily through downstream transcriptomic and cellular regulator pathways to influence broader metabolic homeostasis and gene expression. While SS-31 provides localized organelle restoration, Cell Factor targets systemic cellular adaptation.
Researchers evaluating mitochondrial bioenergetics often choose between direct-acting organelle-targeted compounds like SS-31 and multi-pathway cellular modulators. SS-31 (also known as Elamipretide or MTP-131) is a synthetic tetrapeptide engineered to penetrate cell membranes independently of membrane potential and selectively concentrate at the inner mitochondrial membrane (IMM). Cell Factor, by comparison, operates as a comprehensive signaling factor studied for its broader downstream effects on cellular stress responses, transcriptomic profile shifts, and metabolic rate regulation in diverse cell populations.
Understanding these foundational differences allows principal investigators to configure high-fidelity in vitro and animal assays that accurately test targeted hypotheses regarding oxidative stress, ATP yield, mitochondrial dynamics, and cellular longevity.
To assist laboratory personnel in protocol selection and experimental design, the core biochemical parameters of SS-31 and Cell Factor are summarized below. Data reflect synthesized literature from published rodent and in vitro models.
| Parameter | SS-31 (Elamipretide) | Cell Factor | | :--- | :--- | :--- | | Primary Receptor / Target | Cardiolipin (Inner Mitochondrial Membrane) | Cellular Transcriptional & Regulatory Networks | | Mechanistic Class | Mitochondrial-Targeted Antioxidant & Bioenergetic Restorative | Broad-Spectrum Cellular Bio-Regulator | | Reported Preclinical Half-Life | ~2–4 hours (plasma); extended organelle retention | ~1–3 hours (plasma); sustained secondary signaling | | Aqueous Solubility | Highly soluble in sterile water / bacteriostatic water | Soluble in buffered aqueous solutions (PBS, saline) | | Primary Preclinical Models | Ischemia-reperfusion, neurodegeneration, cardiotoxicity, aging models | Cellular senescence, tissue regeneration, metabolic stress assays | | Available Unit Sizes | 10mg, 50mg lyophilized vials | Standard research-grade unit sizes (see catalog) |
These parameters demonstrate that while both compounds are utilized in cellular stress and longevity research, their primary sites of action dictate different experimental setups, dilution buffers, and assay timelines across our full range of research peptides.
SS-31 possesses a unique structural motif consisting of alternating aromatic residues and basic amino acids (D-Arg-dimethylTyr-Lys-Phe-NH2). This structural arrangement allows the peptide to cross the plasma membrane easily due to its net positive charge, while its lipophilic properties facilitate insertion into the lipid bilayer of the inner mitochondrial membrane.
Preclinical studies show that SS-31 binds electrostatically and hydrophobically to cardiolipin, an essential phospholipid exclusive to the IMM. Cardiolipin is critical for stabilizing the structural integrity of mitochondrial cristae, organizing electron transport chain (ETC) complexes into functional supercomplexes, and maintaining cytochrome c retention.
When cardiolipin undergoes peroxidation during pathological oxidative stress, electron leak increases, reducing ATP output and generating excessive free radicals. In vitro assays demonstrate that SS-31 binding protects cardiolipin from oxidative degradation, prevents cytochrome c peroxidase activity, decreases ROS production, and restores optimal oxidative phosphorylation without uncoupling the mitochondrial proton gradient.
Cell Factor represents a class of complex regulatory research compounds designed to modulate broad-spectrum cellular signaling pathways rather than a single lipid target. Preclinical literature indicates that Cell Factor plays a role in upregulating endogenous cell defense mechanisms, modulating cytokine transcription profiles, and enhancing cellular repair machinery in compromised tissue models.
In cell culture models of oxidative or nutrient deprivation stress, exposure to Cell Factor has been observed to alter the expression of key metabolic regulators, including sirtuin pathways and nuclear respiratory factors. This suggests a top-down regulatory mechanism, where the compound triggers intracellular signaling cascades that lead to adaptive gene transcription.
Unlike SS-31, which acts rapidly on local mitochondrial membrane mechanics, Cell Factor’s biochemical effects typically manifest over extended incubations in cell culture or repeated administration protocols in rodent models. Researchers measuring long-term cellular adaptation, epigenetic modification, or structural tissue repair often incorporate Cell Factor into multi-variable research panels.
Comparing SS-31 and Cell Factor highlights two fundamental approaches to cellular stress research: direct structural stabilization of organelle machinery versus indirect network-level transcriptomic activation.
Preclinical data show that SS-31 operates as a immediate-phase kinetic agent. By binding cardiolipin, it directly alters the physical microenvironment of the ETC, maintaining electron flow even under acute ischemic or toxic insults. This immediate physical interaction makes SS-31 an effective tool for studying acute organelle crisis, such as ischemia-reperfusion injury in cardiac or renal cell lines.
Conversely, Cell Factor acts primarily through signal transduction cascades. Its addition to cell cultures initiates systemic adaptive responses that alter mitochondrial biogenesis, autophagy rates, and antioxidant gene transcription over hours or days. When designing experiments that probe structural mitochondrial dynamics, SS-31 serves as an isolated organelle probe, whereas Cell Factor provides a broader lens for evaluating integrated cellular resilience.
Selecting between SS-31 and Cell Factor depends directly on the experimental endpoint required by the laboratory protocol. Below are standard research scenarios and the corresponding compound alignment based on published literature:
1. **Acute Oxidative Stress & Ischemia Models:** When studying acute loss of membrane potential, cytochrome c release, or immediate ROS spikes, SS-31 is the compound of choice due to its direct IMM accumulation and cardiolipin protection mechanisms. 2. **Mitochondrial Supercomplex Assembly Assays:** For native PAGE analysis of respiration complexes and cristae morphology, SS-31 offers a targeted molecular tool to study structural integrity. 3. **Long-Term Senescence and Adaptive Response Studies:** When evaluating long-term survival, stress tolerance pathways, or transcriptional signaling changes across multiple passages, Cell Factor provides a comprehensive model of systemic cell preservation. 4. **Dual-Target Protocol Architectures:** Advanced research protocols frequently combine direct mitochondrial stabilizers with transcriptomic regulators to evaluate synergistic protective effects in complex disease models.
Principal investigators should ensure that solvent compatibility, incubation time, and assay readouts match the kinetic profile of each compound. Detailed chemical parameters and batch-specific analytical reports can be reviewed via our official certificate of analysis hub.
Proper reconstitution and handling are critical to preserving peptide integrity and ensuring reproducible quantitative assay data. Both SS-31 and Cell Factor are supplied as high-purity, lyophilized powders that require correct aseptic laboratory technique.
For lyophilized SS-31, reconstitution in sterile bacteriostatic water or sterile normal saline (0.9% NaCl) yields high solubility at room temperature. For specialized cell culture protocols, stock solutions can be prepared using sterile phosphate-buffered saline (PBS, pH 7.4). Avoid high-shear vortexing; gentle agitation or mild inversion is recommended to achieve complete dissolution.
Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to eliminate freeze-thaw degradation and stored at -20°C or -80°C for long-term stability. To calculate accurate working concentrations, reconstitution volumes, and molarities for in vitro dosing, researchers can utilize the online PX1 reconstitution calculator.
SS-31 and Cell Factor exist within a broader landscape of bioenergetic and cellular regulator research peptides. Researchers evaluating organelle-targeted therapies often compare these agents with other key preclinical compounds such as MOTS-c and Epithalon.
While SS-31 directly binds cardiolipin inside the mitochondria, MOTS-c is a mitochondrial-derived peptide (MDP) that translocates to the nucleus under metabolic stress to regulate nuclear gene expression and glucose homeostasis. Meanwhile, Epithalon operates predominantly on the epigenetic level by modulating telomerase activity and chromatin structure in nuclear DNA. Combining these distinct classes in comparative research panels allows laboratories to map out cellular signaling from the inner organelle membrane to the nuclear genome.
Every research compound offered by PX1 Research undergoes strict analytical testing to confirm identity, purity, and freedom from contaminants before deployment in laboratory environments. Additional information on peptide synthesis pathways and quality controls is detailed in our research library hub.
To achieve reproducible data in preclinical research, compound purity and batch consistency are essential. Contaminants such as trifluoroacetate (TFA) residual salts, heavy metals, or bacterial endotoxins can introduce confounding variables in delicate cell culture and animal models.
PX1 Research manufactures all research compounds within state-of-the-art, GMP-compliant facilities located in the USA. Every lot of SS-31 and Cell Factor undergoes rigorous analytical testing in an ISO 17025 accredited laboratory. Purity is verified to exceed 99% via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis, and endotoxin testing is conducted to guarantee low levels compatible with sensitive cell assays.
Laboratories and institutional accounts requiring bulk quantities or specialized lot reservation can explore our institutional programs at the wholesale hub. All orders ship same-day (Monday through Friday) directly from our distribution facilities in California and Arizona.
What is the primary mechanistic difference between SS-31 and Cell Factor?
SS-31 (Elamipretide) selectively targets and binds cardiolipin on the inner mitochondrial membrane to directly stabilize cristae and reduce ROS. Cell Factor operates via downstream intracellular signaling networks to influence broader transcriptomic adaptions and cellular metabolic homeostasis.
Are SS-31 and Cell Factor approved for human administration?
No. Both SS-31 and Cell Factor are supplied strictly as research compounds for in vitro laboratory experimentation and preclinical animal models. They are not intended for human or veterinary use, therapy, or clinical administration.
What solvent is recommended for reconstituting lyophilized SS-31 for lab use?
SS-31 is highly soluble in sterile water for injection, bacteriostatic water, or phosphate-buffered saline (PBS, pH 7.4). Researchers should follow aseptic technique and gently invert the vial to achieve full solution.
How should reconstituted stock solutions of these peptides be stored?
Reconstituted stock solutions should be divided into single-use aliquots to prevent repeated freeze-thaw cycles and stored at -20°C or -80°C. Working aliquots can be stored temporarily at 4°C for short duration protocols.
Where can I view the Certificate of Analysis (COA) for PX1 Research peptides?
Lot-specific Certificates of Analysis featuring HPLC purity profiles, Mass Spectrometry verification, and endotoxin assay reports are publicly accessible via the PX1 COA portal.
How does SS-31 compare to MOTS-c in mitochondrial research?
SS-31 acts physically on the inner mitochondrial membrane by binding cardiolipin, whereas MOTS-c is a mitochondrial-derived peptide that translocates to the cell nucleus to modulate metabolic gene expression during stress.
What purity levels are guaranteed for PX1 Research peptides?
All PX1 research peptides are synthesized in USA-based, GMP-compliant facilities and verified via HPLC/MS in ISO 17025 accredited labs to achieve ≥98-99% purity with strict endotoxin testing.
How fast are research orders processed and shipped?
Orders placed Monday through Friday ship same-day from PX1 fulfillment centers located in California and Arizona to minimize turnaround time for laboratory workflows.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.